Doctor-led aesthetics in Sutton Coldfield
MDr MaryamAesthetics

Polynucleotides

Polynucleotides for dark circles: reading the 2026 study carefully

A 2026 observational study reported improvement in dark-circle severity after three polynucleotide sessions, but its open-label design cannot prove how much change came from the treatment itself.

5 minute read

Dark circles are not one diagnosis

The appearance called ‘dark circles’ may result from increased pigment, visible blood vessels, thin skin, irritation or rubbing, a tear-trough hollow, lower-eyelid bags, shadowing, or several of these together. A treatment aimed at skin quality cannot be expected to correct every cause, and the first step is to identify the dominant feature.

This distinction matters when reading research. A photograph may look brighter because pigment has changed, because the skin surface reflects light differently or because a hollow casts less shadow. Improvement in the overall appearance of a dark circle does not necessarily mean that melanin or another specific pigment has been removed.

What did the 2026 real-world study involve?

The multinational study followed 61 adults aged 20 to 67 who were troubled by dark circles of different structural, vascular, pigmented and mixed types. Participants received three sessions of a low-concentration, trout-derived polynucleotide hydrogel, usually two to three weeks apart, using a needle, cannula or both.

Photographs were taken before treatment and at one and three months after the final session. Researchers used a photonumeric dark-circle scale and digital analysis of colour and pigmentation. Treating specialists and participants also rated hyperpigmentation and aspects of skin quality such as tone, firmness and glow.

Dark-circle grades improved over time

The distribution of dark-circle grades shifted towards lower severity after treatment, with a statistically significant change from baseline. Improvement appeared strongest in participants treated by needle whose dark circles had an important structural component. Specialist and participant ratings also improved between the one- and three-month follow-ups.

These findings suggest that the treatment deserves further study, particularly where skin quality and contour contribute to the shadow. They do not show that polynucleotides reliably lighten every type of pigmentation, remove visible vessels or replace volume where a pronounced hollow is the main concern.

Why the study cannot prove cause and effect

This was an open-label observational study with no untreated, placebo or alternative-treatment group. Everyone knew that treatment had been given. Changes in lighting, camera position, skincare, sun exposure, natural fluctuation and expectations therefore cannot be separated fully from the effect of the injections.

Dose and delivery technique could vary between clinicians, and the study combined several dark-circle subtypes. The product manufacturer funded the article-processing charge, and some authors disclosed grants, consultancy fees or other support from aesthetic-product companies. These links do not invalidate the findings, but independent controlled trials are needed before broad claims are justified.

Statistical change is not a guaranteed visible result

A significant average shift on a grading scale does not predict how much change one person will see or whether they will consider it worthwhile. The 2026 systematic review of randomised PN and PDRN research found only seven trials with 183 participants across several different uses, products and protocols, highlighting how limited the wider evidence remains.

Consultation should define whether the goal is smoother texture, less shadow, improved hydration or true pigment reduction. Consistent photographs and a planned review can help assess response. Depending on the cause, skincare, allergy or eczema management, another procedure, medical assessment or no injectable may be more appropriate.

Downtime, warning signs and suitability

Twenty-one participants reported mild effects such as swelling or redness, usually settling within hours or the same day; in two, swelling and local firmness lasted under three days. Outside a small study, raised points, tenderness, itching, pinpoint bleeding or bruising may also occur. Increasing pain, heat, spreading redness, discharge, unusual skin colour, marked swelling, eye pain or visual symptoms need prompt assessment.

The exact product, allergies—including fish allergy where relevant—medical conditions, medicines, pregnancy or breastfeeding, previous reactions and planned procedures must be reviewed. Active infection, dermatitis or inflammation may mean postponing treatment. GMC guidance requires clear discussion of evidence, risks, alternatives and follow-up. A careful assessment should come before any treatment course or promise about dark circles.

← Back to the journal

Personalised medical assessment

Questions about treatment?

Book a consultation to discuss your concerns, health and treatment options without pressure.

Free consultation – a £1 booking fee secures your appointment